TrialEpigenetics2022

Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance).

Lynn Symonds et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.